Shoulder Innovations (NYSE:SI) Major Shareholder Sells 28,245 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $23.36, for a total value of $659,803.20. Following the completion of the transaction, the insider owned 2,352,237 shares in the company, valued at approximately $54,948,256.32. This represents a 1.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.

Shoulder Innovations Trading Down 1.4%

SI traded down $0.33 on Monday, hitting $22.41. 65,637 shares of the company were exchanged, compared to its average volume of 92,187. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. The firm has a fifty day simple moving average of $19.19 and a two-hundred day simple moving average of $15.79. The stock has a market capitalization of $464.89 million and a PE ratio of -0.13. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59.

Shoulder Innovations (NYSE:SI) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.03. The firm had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%. Sell-side analysts expect that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Shoulder Innovations in a report on Monday, June 29th. UBS Group initiated coverage on shares of Shoulder Innovations in a research report on Tuesday, July 28th. They issued a “buy” rating and a $27.00 price objective on the stock. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price objective (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $22.00.

Institutional Investors Weigh In On Shoulder Innovations

Large investors have recently made changes to their positions in the business. Deerfield Management Company L.P. bought a new position in Shoulder Innovations in the third quarter worth about $6,056,000. Alyeska Investment Group L.P. purchased a new position in shares of Shoulder Innovations during the 3rd quarter worth approximately $5,667,000. Vanguard Group Inc. purchased a new position in shares of Shoulder Innovations during the 3rd quarter worth approximately $1,836,000. Roubaix Capital LLC raised its position in shares of Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares in the last quarter. Finally, Millennium Management LLC purchased a new position in shares of Shoulder Innovations in the 4th quarter valued at approximately $1,316,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.